Martin Strebl-Bantillo PhD

Martin Strebl-Bantillo is a principal at Lumanity. He has extensive expertise in primary market research and strategy development to support new product commercialization across a range of therapeutic areas, with a focus on oncology and transplant care.

Prior to joining Lumanity, Martin received his PhD in Chemistry & Chemical Biology from Harvard University and completed a postdoctoral fellowship in Neuroimaging at MGH/Harvard Medical School. His research focused on chemical methodology of introducing radioactive labels into small molecules, and the applications of his technology in PET-based visualization of epigenetic enzymes in the living brain.

Outside the office, Martin enjoys food, orchids, and reading about a range of topics. He loves traveling with his husband and practicing his foreign language skills on unsuspecting locals.

Martin completed his BSc in Chemistry and Biochemistry from LMU Munich in his native Germany.